edgepedia

Life and health

72,234 articles

Kazuko Nishikura

Kazuko Nishikura is a Japanese-born molecular biologist and professor at The Wistar Institute in Philadelphia, known for discovering A-to-I RNA editing and characterizing the ADAR enzyme family.

Kazuko Yamaguchi-Shinozaki

Kazuko Yamaguchi-Shinozaki (篠崎 和子, born 1954) is a Japanese plant molecular biologist who discovered the DRE element and DREB transcription factors, key to drought tolerance in crops.

Kazuo Shinozaki

Kazuo Shinozaki, born in 1949, is a Japanese plant molecular biologist at RIKEN who discovered the major gene-regulatory systems governing plant drought response and was elected to the US National Academy of Sciences in 2020.

Kazuo Tsubota

Kazuo Tsubota (坪田一男) is a Japanese ophthalmologist known for research on dry eye, myopia, and corneal regenerative medicine, who was professor of ophthalmology at Keio University from 2004 to 2021 and now leads Tsubota Laboratory.

Kazushige Touhara

Kazushige Touhara (東原 和成) is a Japanese sensory neuroscientist, professor at the University of Tokyo, known for discovering the mouse pheromone ESP1 and showing insect olfactory receptors are ion channels.

Kazutaka Katoh

Kazutaka Katoh (加藤 和貴) is a Japanese computational biologist and professor at the University of Tokyo, known for developing the widely used MAFFT multiple sequence alignment program.

Kazutoshi Mori

Kazutoshi Mori (森和俊, born 1958) is a Japanese cell biologist who discovered the unfolded protein response, a cellular quality-control system, and shared the 2014 Lasker Award.

Kazuwa Nakao

Kazuwa Nakao (中尾 一和) is a Japanese endocrinologist and physician-scientist at Kyoto University whose laboratory carried natriuretic peptides and leptin from discovery into clinical use.

Kazuyuki Sugahara

Kazuyuki Sugahara (菅原一幸) is a Japanese biochemist known for his work on glycosaminoglycan biosynthesis, including the 2001 cloning of human chondroitin synthase, who held professorships at Kobe Pharmaceutical and Hokkaido Universities.

KBG syndrome

KBG syndrome (OMIM #148050) is a rare autosomal dominant neurodevelopmental disorder caused by ANKRD11 variants or 16q24.3 deletions, marked by macrodontia of upper central incisors, distinctive facial features, short stature, and developmental delay.

KCNE1

KCNE1 (MinK, IsK) is a human gene on chromosome 21q22.12 encoding a 129-residue single-pass beta subunit that modulates KCNQ1 to form the cardiac IKs potassium channel; variants cause long QT syndrome type 5 and Jervell and Lange-Nielsen syndrome.

KCNH1

KCNH1 (Eag1, Kv10.1) is a human gene at 1q32.2 encoding a voltage-gated potassium channel, brain-restricted in healthy tissue, overexpressed in about 70% of tumors, and mutated in Zimmermann-Laband and Temple-Baraitser syndromes.

KCNH6

KCNH6 (ERG2, Kv11.2) is a human chromosome 17 gene encoding a pore-forming voltage-gated potassium channel alpha subunit of the Kv11/ERG family, expressed in kidney and small intestine, linked to insulin secretion, heterotaxy, and Long QT Syndrome 2.

KCNJ11

KCNJ11 (Kir6.2) gene on 11p15.1 encoding the pore-forming beta-cell KATP channel subunit; inactivating variants cause congenital hyperinsulinism, activating variants neonatal diabetes and MODY13, treatable with sulfonylureas.

KCNJ2

KCNJ2 (KIR2.1, IRK1, LQT7) is a human chromosome 17q24.3 gene encoding the Kir2.1 inwardly rectifying potassium channel of cardiac and skeletal muscle; mutations cause Andersen-Tawil syndrome, short QT syndrome type 3, and familial atrial fibrillation.

KCNJ5

KCNJ5 (GIRK4, Kir3.4, LQT13) is a human gene at 11q24.3 encoding a G-protein-gated inward rectifier potassium channel; mutations cause aldosterone-producing adenomas, familial hyperaldosteronism type III, and disputed long QT syndrome.

KCNMA1

KCNMA1 (SLO, MaxiK, KCa1.1, PNKD3) is the human gene at 10q22.3 encoding the BK calcium- and voltage-activated potassium channel alpha subunit; its mutations cause KCNMA1-linked channelopathy with dyskinesia, seizures, and developmental delay.

KCNQ1

KCNQ1 (KvLQT1, Kv7.1) is a human chromosome 11 gene encoding a voltage-gated potassium channel; with KCNE1 it forms cardiac IKs current, and mutations cause long QT, Jervell and Lange-Nielsen, and atrial fibrillation.

KCNQ1OT1

KCNQ1OT1 (Kcnq1 opposite strand/antisense transcript 1) is a ~60 kb paternally expressed antisense lncRNA on human chromosome 11p15.5 that silences imprinted genes in the Kcnq1 domain in cis and acts as an oncogenic miRNA sponge in cancers.

KCNQ2

KCNQ2 is a human gene on chromosome 20 encoding the Kv7.2 potassium channel, where pathogenic variants cause neonatal epilepsy ranging from mild to severe encephalopathy.

KCNQ2-related developmental and epileptic encephalopathy

KCNQ2-related developmental and epileptic encephalopathy (KCNQ2-DEE) is a rare neonatal epilepsy syndrome caused by KCNQ2 gene variants, with seizures starting in the first week of life.

KCONVAC (Shenzhen Kangtai inactivated COVID-19 vaccine)

KCONVAC (康泰疫苗) is Shenzhen Kangtai's inactivated Vero-cell COVID-19 vaccine, authorized in China on 5 February 2021 with 79.34% efficacy, later discontinued after market changes.

KD [Human lip fibroblast]

KD [Human lip fibroblast], synonym Karen Day, CVCL_2970/JCRB9103, a finite human lip fibroblast cell line from a 31-year-old female donor, used in DNA repair, transformation, and cleft lip research.

KDM1A

KDM1A (LSD1, AOF2) is the first-discovered human histone demethylase, a FAD-dependent enzyme acting on H3K4me1/2 and H3K9me1/2, overexpressed in cancers and targeted by nine clinical-trial inhibitors including iadademstat and bomedemstat.

KDM3B-related intellectual disability-facial dysmorphism-short stature syndrome

KDM3B-related intellectual disability-facial dysmorphism-short stature syndrome, or Diets-Jongmans syndrome (DIJOS, OMIM 618846), is a rare autosomal dominant disorder from pathogenic KDM3B variants at 5q31, causing intellectual disability, short stature, distinctive facial features, and possible cancer predisposition.

KDM4A

KDM4A (JMJD2A, JHDM3A) is a human JmjC-domain, Fe(II)/2-oxoglutarate-dependent histone demethylase of H3K9me2/3, H3K36me2/3, and H1.4K26, the first demethylase shown to act on trimethylated lysines, amplified in 20% of TCGA cancers and a drug target.

KDM5A

KDM5A (JARID1A, RBBP2), gene at 12p13.33 encoding a JARID1-family histone H3K4me2/3 demethylase (EC 1.14.11.67) that regulates Hox genes, interacts with retinoblastoma protein, and is linked to neurodevelopmental disorder, leukemia, and cancer drug targeting.

KDM5B

KDM5B (PLU-1, JARID1B), gene at 1q32.1, encodes a 1544-aa Fe(II)/2-OG-dependent H3K4me3/2/1 demethylase of the KDM5 family; a transcriptional repressor in development, stem cells, and cancer, generally oncogenic in solid tumors but tumor-suppressive in MLL-rearranged AML.

KDM5C

KDM5C (SMCX, JARID1C) is an Xp11.22 gene encoding lysine demethylase 5C, an Fe(II)- and 2-oxoglutarate-dependent H3K4me2/3 demethylase; loss-of-function variants cause Claes-Jensen X-linked intellectual disability and it has context-dependent cancer roles.

KDM5C-related syndromic X-linked intellectual disability

KDM5C-related syndromic X-linked intellectual disability, also called Claes-Jensen syndrome (OMIM 300534), is a rare X-linked recessive neurodevelopmental disorder caused by KDM5C histone demethylase variants, causing intellectual disability, speech delay, seizures, and short stature, mainly in males.